BOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced Hello Heart, the digital leader in preventive heart health, is a partner in the Amwell clinical programs portfolio available on the Amwell Converge™ platform. Amwell health plan clients can now offer their employer accounts the Hello Heart cardiovascular solution to eligible members and employees with high blood pressure, high cholesterol, or other risk factors for cardiovascular ...

Group 1 - Amwell will participate in several investor conferences in September, including the Morgan Stanley 22nd Annual Global Healthcare Conference and the Wells Fargo Healthcare Conference [1] - Ido Schoenberg, M.D., Amwell's chairman and CEO, and Robert Shepardson, Amwell's CFO, will engage in fireside chats and one-on-one meetings during these conferences [1] - The company emphasizes its role as a leader in hybrid care delivery, connecting providers, payers, patients, and innovators to enhance access to affordable, high-quality care [3] Group 2 - Amwell's platform supports a wide range of digital health needs, including urgent, acute, post-acute care, chronic care management, and healthy living [3] - The company has nearly two decades of experience and powers the digital care of over 50 health plans, representing more than 100 million covered lives [3] - Amwell believes that hybrid care delivery will transform the healthcare landscape [3]

Core Insights - American Well Corporation (AMWL) reported revenue of $62.79 million for the quarter ended June 2024, reflecting a 0.5% increase year-over-year and a 3.30% surprise over the Zacks Consensus Estimate of $60.78 million [1] - The company's EPS was -$3.36, an improvement from -$4.60 in the same quarter last year, with a positive surprise of 14.72% compared to the consensus estimate of -$3.94 [1] Revenue Breakdown - Platform subscription revenue was $27.50 million, slightly below the average estimate of $26.32 million, representing a year-over-year decline of 1.9% [3] - Other revenue reached $6.56 million, exceeding the average estimate of $5.35 million, marking a year-over-year increase of 3.5% [4] - Revenue from visits totaled $28.73 million, slightly below the average estimate of $28.95 million, with a year-over-year increase of 2.3% [5] Stock Performance - American Well's shares have increased by 42.2% over the past month, contrasting with a -0.4% change in the Zacks S&P 500 composite [5] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [5]

American Well Corporation (NYSE:AMWL) Q2 2024 Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Craig Hettenbaugh - Morgan Stanley Jack Wallace - Guggenheim Securities Matthew Shea - Needham & Company Jenny Cao - Truist Securities Jessica Tassan - Piper Sandler David - from BTIG Charles Rhyee - TD Cowen Operator Good after ...

Telehealth provider Amwell on Wednesday (July 31) reported second-quarter revenue of $62.8 million (above guidance of $61.1 million), driven by $27.5 million in subscription revenue and $28.7 million from visits to Amwell Medical Group (AMG).Despite a net loss of $49.9 million — down from $73.4 million in Q1 2024 — Amwell achieved a reduced adjusted EBITDA loss of $35 million, compared to $45.7 million in the prior quarter. Amwell’s gross margin stood at 37% while total visits reached 1.5 million, with abou ...

American Well Corporation (AMWL) came out with a quarterly loss of $3.36 per share versus the Zacks Consensus Estimate of a loss of $3.94. This compares to loss of $4.60 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.72%. A quarter ago, it was expected that this company would post a loss of $3.60 per share when it actually produced a loss of $5, delivering a surprise of -38.89%.Over the last four quarters, the company has ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39515 American Well Corporation (Exact name of registrant as specified in its charter) Delaware 20-5009396 (State of incorporation) ...

Exhibit 99.1 amwell 2 AMWELL ANNOUNCES RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2024 BOSTON, July 31, 2024 – Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, today announced financial results for the second quarter of 2024. "In Q2, we drove progress on all fronts. We continued the deployment of our solution for the U.S. Military Health System and our ongoing rigorous cost alignment efforts resulted in an improved outlook for 2024 adjusted EBITDA," said Ido Schoenberg, M.D. chairman and CEO of ...

Boston, July 31, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the second quarter 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, July 31. The call can be accessed via a live audio w ...

Wall Street expects a year-over-year increase in earnings on lower revenues when American Well Corporation (AMWL) reports results for the quarter ended June 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on July 31, 2024, might help the stock move higher if these key numbers are better ...